Fort Baker Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Fort Baker Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.1K	Hold	26,374	–	–	﹤0.01%	118
2026 Q1	$31.6K	Sell	26,374 -100	-0.4%	-$135	﹤0.01%	114
2025 Q4	$43.9K	Buy	+26,474	New	+$33.7K	﹤0.01%	103

Other funds holding TLSIW

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Fort Baker Capital Management's TLSIW Position: Q2 2026 in Review

Fort Baker Capital Management held its TriSalus Life Sciences Warrant (TLSIW) position steady in Q2 2026 at 26,374 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #118.

Fort Baker Capital Management first reported a position in TLSIW in Q4 2025 and has held it in 3 quarters since. The position peaked at $43.9K in Q4 2025. 5 funds tracked by Wall St. Rank hold TLSIW as of Q2 2026.

Fort Baker Capital Management held 26,374 shares of TriSalus Life Sciences Warrant worth $21.1K as of Q2 2026.
Fort Baker Capital Management left its TriSalus Life Sciences Warrant share count unchanged in Q2 2026.
TriSalus Life Sciences Warrant made up ﹤0.01% of Fort Baker Capital Management's portfolio in Q2 2026, its #118 holding.
Fort Baker Capital Management first reported a position in TriSalus Life Sciences Warrant in Q4 2025 and has held it in 3 quarters since.
Fort Baker Capital Management's TriSalus Life Sciences Warrant position peaked at $43.9K in Q4 2025.
5 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2026.

Based on Fort Baker Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.